{
    "root": "26f3b219-18ec-4c4c-86da-6033f6af3185",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Cayston",
    "value": "20250317",
    "ingredients": [],
    "indications": "cayston\u00ae indicated improve respiratory symptoms cystic fibrosis ( cf ) patients pseudomonas aeruginosa . safety effectiveness established pediatric patients age 7 years , patients fev1 < 25 % > 75 % predicted , patients colonized burkholderia cepacia [ ( 14 ) ] . reduce development drug-resistant bacteria maintain effectiveness cayston antibacterial drugs , cayston used treat patients cf known pseudomonas aeruginosa lungs .",
    "contraindications": "administer one dose ( one single vial one ampule diluent ) 3 times day 28 days . ( 2.1 ) dose immediately reconstitution . ( 2.2 ) administer altera \u00ae nebulizer system . administer type nebulizer . ( 2.3 )",
    "warningsAndPrecautions": "kit 28-day course cayston contains 84 sterile vials cayston 88 ampules sterile diluent packed 2 cartons , carton containing 14-day supply . four additional diluent ampules provided case spillage . package configuration strength ndc 28-day kit 75 mg 61958-0901-1",
    "adverseReactions": "cayston contraindicated patients known allergy aztreonam .",
    "indications_original": "CAYSTON\u00ae is indicated to improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa. Safety and effectiveness have not been established in pediatric patients below the age of 7 years, patients with FEV1 <25% or >75% predicted, or patients colonized with Burkholderia cepacia \n                     [see Clinical Studies (14)].\n                  \n                  To reduce the development of drug-resistant bacteria and maintain the effectiveness of CAYSTON and other antibacterial drugs, CAYSTON should be used only to treat patients with CF known to have Pseudomonas aeruginosa in the lungs.",
    "contraindications_original": "Administer one dose (one single use vial and one ampule of diluent) 3 times a day for 28 days. ( 2.1 ) Use dose immediately after reconstitution. ( 2.2 ) Administer only with the Altera \u00ae Nebulizer System. Do not administer with any other type of nebulizer. ( 2.3 )",
    "warningsAndPrecautions_original": "Each kit for a 28-day course of CAYSTON contains 84 sterile vials of CAYSTON and 88 ampules of sterile diluent packed in 2 cartons, each carton containing a 14-day supply. The four additional diluent ampules are provided in case of spillage.\n                  \n                     \n                     \n                     \n                     \n                        \n                           Package Configuration\n                           Dosage Strength\n                           NDC\n                        \n                     \n                     \n                        \n                           28-Day Kit\n                           75 mg\n                           61958-0901-1",
    "adverseReactions_original": "CAYSTON is contraindicated in patients with a known allergy to aztreonam."
}